A citation-based method for searching scientific literature

Noppadol Kietsiriroje, Sam Pearson, Matthew Campbell, Robert A S Ariëns, Ramzi A Ajjan. Diabetes Obes Metab 2019
Times Cited: 11







List of co-cited articles
32 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Can clinical factors estimate insulin resistance in type 1 diabetes?
K V Williams, J R Erbey, D Becker, S Arslanian, T J Orchard. Diabetes 2000
275
63


Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes.
Thomas Nyström, Martin J Holzmann, Björn Eliasson, Ann-Marie Svensson, Ulrik Sartipy. Diabetes Obes Metab 2018
17
36

Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes.
Eric J Epstein, Jamie L Osman, Hillel W Cohen, Swapnil N Rajpathak, Oksana Lewis, Jill P Crandall. Diabetes Care 2013
27
36


Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.
Trevor J Orchard, Jon C Olson, John R Erbey, Katherine Williams, Kimberly Y-Z Forrest, Leslie Smithline Kinder, Demetrius Ellis, Dorothy J Becker. Diabetes Care 2003
316
36

Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes.
Jon C Olson, John R Erbey, Kimberly Y Z Forrest, Katherine Williams, Dorothy J Becker, Trevor J Orchard. Metabolism 2002
48
36



Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis.
Esther Donga, Olaf M Dekkers, Eleonora P M Corssmit, Johannes A Romijn. Eur J Endocrinol 2015
37
27


Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.
Irene E Schauer, Janet K Snell-Bergeon, Bryan C Bergman, David M Maahs, Adam Kretowski, Robert H Eckel, Marian Rewers. Diabetes 2011
141
27

Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Jonathan Q Purnell, Barbara H Braffett, Bernard Zinman, Rose A Gubitosi-Klug, William Sivitz, John P Bantle, Georgia Ziegler, Patricia A Cleary, John D Brunzell. Diabetes Care 2017
40
27




Effect of parental type 2 diabetes on offspring with type 1 diabetes.
Lena M Thorn, Carol Forsblom, Johan Wadén, Jenny Söderlund, Milla Rosengård-Bärlund, Markku Saraheimo, Outi Heikkilä, Kustaa Hietala, Kim Pettersson-Fernholm, Jorma Ilonen,[...]. Diabetes Care 2009
13
18


The efficacy and safety of DPP4 inhibitors in patients with type 1 diabetes: A systematic review and meta-analysis.
Heming Guo, Chen Fang, Yun Huang, Yufang Pei, Linqi Chen, Ji Hu. Diabetes Res Clin Pract 2016
33
18

Adiposity and mortality in type 1 diabetes.
B Conway, R G Miller, T Costacou, L Fried, S Kelsey, R W Evans, T J Orchard. Int J Obes (Lond) 2009
46
18

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.
John R Petrie, Nishi Chaturvedi, Ian Ford, Martijn C G J Brouwers, Nicola Greenlaw, Therese Tillin, Irene Hramiak, Alun D Hughes, Alicia J Jenkins, Barbara E K Klein,[...]. Lancet Diabetes Endocrinol 2017
134
18

Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?
S J Cleland, B M Fisher, H M Colhoun, N Sattar, J R Petrie. Diabetologia 2013
100
18


Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
Ingrid M Libman, Kellee M Miller, Linda A DiMeglio, Kathleen E Bethin, Michelle L Katz, Avni Shah, Jill H Simmons, Michael J Haller, Sripriya Raman, William V Tamborlane,[...]. JAMA 2015
96
18

The use of metformin in type 1 diabetes: a systematic review of efficacy.
S Vella, L Buetow, P Royle, S Livingstone, H M Colhoun, J R Petrie. Diabetologia 2010
120
18


Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks.
Nitesh D Kuhadiya, Sandeep Dhindsa, Husam Ghanim, Aditya Mehta, Antoine Makdissi, Manav Batra, Sartaj Sandhu, Jeanne Hejna, Kelly Green, Natalie Bellini,[...]. Diabetes Care 2016
43
18


Omega-3 polyunsaturated fatty acid supplementation versus placebo on vascular health, glycaemic control, and metabolic parameters in people with type 1 diabetes: a randomised controlled preliminary trial.
Lauren L O'Mahoney, Gareth Dunseath, Rachel Churm, Mel Holmes, Christine Boesch, Antonios Stavropoulos-Kalinoglou, Ramzi A Ajjan, Karen M Birch, Nicolas M Orsi, Georgia Mappa,[...]. Cardiovasc Diabetol 2020
3
66

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.
Katherine Kearney, Darren Tomlinson, Kerrie Smith, Ramzi Ajjan. Cardiovasc Diabetol 2017
50
18

The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes.
Maria J Redondo, Carmella Evans-Molina, Andrea K Steck, Mark A Atkinson, Jay Sosenko. Diabetes Care 2019
15
18

Prevalence and comorbidities of double diabetes.
S R Merger, W Kerner, M Stadler, A Zeyfang, P Jehle, M Müller-Korbsch, R W Holl. Diabetes Res Clin Pract 2016
32
18

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.
Zobair M Younossi, Deirdre Blissett, Robert Blissett, Linda Henry, Maria Stepanova, Youssef Younossi, Andrei Racila, Sharon Hunt, Rachel Beckerman. Hepatology 2016
436
9

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Kento Imajo, Takaomi Kessoku, Yasushi Honda, Wataru Tomeno, Yuji Ogawa, Hironori Mawatari, Koji Fujita, Masato Yoneda, Masataka Taguri, Hideyuki Hyogo,[...]. Gastroenterology 2016
339
9

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.
Quentin M Anstee, Giovanni Targher, Christopher P Day. Nat Rev Gastroenterol Hepatol 2013
841
9

Low prevalence of non-alcoholic fatty liver disease in patients with type 1 diabetes is associated with decreased subclinical cardiovascular disease.
Enric Serra-Planas, Eva Aguilera, Laura Castro, Raúl Rodríguez, Isabel Salinas, Anna Lucas, Clara Joaquín, Rocio Puig, Dídac Mauricio, Manel Puig-Domingo. J Diabetes 2017
6
16

Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus.
Zeinab A Elkabbany, Nancy S Elbarbary, Eman A Ismail, Nesrine A Mohamed, Dina Ragab, Shereen Abdel Alem, Yasmine M Ezzat, Sarah S Maurice, Noha U Hashem. J Diabetes Complications 2017
7
14

Can Fetuin-A Be a Marker for Insulin Resistance and Poor Glycemic Control in Children with Type 1 Diabetes Mellitus?
Ülkü Gül Şiraz, Murat Doğan, Nihal Hatipoğlu, Sabahattin Muhtaroğlu, Selim Kurtoğlu. J Clin Res Pediatr Endocrinol 2017
5
20

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
Zobair M Younossi, Pegah Golabi, Leyla de Avila, James Minhui Paik, Manirath Srishord, Natsu Fukui, Ying Qiu, Leah Burns, Arian Afendy, Fatema Nader. J Hepatol 2019
268
9

Prevalence and natural history of histologically proven chronic liver disease in a longitudinal cohort of patients with type 1 diabetes.
David J Harman, Philip V Kaye, Rebecca Harris, Ayako Suzuki, Anastasios Gazis, Guruprasad P Aithal. Hepatology 2014
14
9

Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement.
Damian Hoy, Peter Brooks, Anthony Woolf, Fiona Blyth, Lyn March, Chris Bain, Peter Baker, Emma Smith, Rachelle Buchbinder. J Clin Epidemiol 2012
833
9

The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Yiwen Shi, Qianyi Wang, Yameng Sun, Xinyan Zhao, Yuanyuan Kong, Xiaojuan Ou, Jidong Jia, Shanshan Wu, Hong You. J Clin Gastroenterol 2020
20
9

2018 Annual Report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation.
René Adam, Vincent Karam, Valérie Cailliez, John G O Grady, Darius Mirza, Daniel Cherqui, Jurgen Klempnauer, Mauro Salizzoni, Johann Pratschke, Neville Jamieson,[...]. Transpl Int 2018
106
9

Magnetic resonance imaging reveals altered distribution of hepatic fat in children with type 1 diabetes compared to controls.
Simon E Regnell, Pernilla Peterson, Lena Trinh, Per Broberg, Peter Leander, Åke Lernmark, Sven Månsson, Helena Elding Larsson. Metabolism 2015
21
9

Liver Function and Risk of Type 2 Diabetes: Bidirectional Mendelian Randomization Study.
N Maneka G De Silva, Maria Carolina Borges, Aroon D Hingorani, Jorgen Engmann, Tina Shah, Xiaoshuai Zhang, Jian'an Luan, Claudia Langenberg, Andrew Wong, Diana Kuh,[...]. Diabetes 2019
23
9

Screening for liver fibrosis by using FibroScan(®) and FibroTest in patients with diabetes.
Victor de Lédinghen, Julien Vergniol, Concepcion Gonzalez, Juliette Foucher, Elisa Maury, Louise Chemineau, Sandrine Villars, Henri Gin, Vincent Rigalleau. Dig Liver Dis 2012
37
9

Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.
Giovanni Targher, Amedeo Lonardo, Christopher D Byrne. Nat Rev Endocrinol 2018
125
9

Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.
Alessandro Mantovani, Lucia Mingolla, Riccardo Rigolon, Isabella Pichiri, Valentina Cavalieri, Giacomo Zoppini, Giuseppe Lippi, Enzo Bonora, Giovanni Targher. Int J Cardiol 2016
27
9

Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
Stefano Ballestri, Stefano Zona, Giovanni Targher, Dante Romagnoli, Enrica Baldelli, Fabio Nascimbeni, Alberto Roverato, Giovanni Guaraldi, Amedeo Lonardo. J Gastroenterol Hepatol 2016
311
9

Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes.
T-T Li, A-P Wang, J-X Lu, M-Y Chen, C-C Zhao, Z-H Tang, L-X Li, W-P Jia. Diabetes Metab 2018
2
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.